Changes in peripheral mitochondrial DNA copy number in metformin-treated women with polycystic ovary syndrome: a longitudinal study.
CONCLUSIONS: Treatment with metformin is associated with a time-dependent decrease in mtDNA-CN in patients with PCOS who are treated over the course of one year. This may signify a reduction in mitochondria dysfunction. The change in mtDNA-CN corresponds to a similar change in serum total testosterone, and suggests a possible relationship between mtDNA-CN and testosterone.
TRIAL REGISTRATION: ClinicalTrials.gov , NCT00172523 . Registered September 15, 2005.
PMID: 32660613 [PubMed - in process]
Source: Reproductive Biology - Category: Reproduction Medicine Authors: Yang PK, Chou CH, Chang CH, Chen SU, Ho HN, Chen MJ Tags: Reprod Biol Endocrinol Source Type: research
More News: Biology | Fortamet | Liver | Metformin | Mitochondria | Ovaries | Polycystic Ovary Syndrome | Reproduction Medicine | Study | Urology & Nephrology | Women